Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medical Instrument Development Laboratories (MID Labs) is a specialized medical device company focused on the design, engineering, and manufacturing of advanced ophthalmic surgical instruments. Founded in 1981 and headquartered in San Leandro, California, the company is a global leader in vitreoretinal surgery technology, particularly known for its vitrectomy cutters and cannula insertion systems. MID Labs' products, including the Bi-Blade vitreous cutter and the Single-Step Cannula Insertion System, are designed to improve surgical precision and patient outcomes in treating conditions such as retinal detachment and diabetic retinopathy. In 2019, the company was acquired by HOYA Surgical Optics, further expanding its global reach and integration into comprehensive ophthalmic surgical solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Instrument Development.